ASCO Annual Meeting Highlights Benefits of Droplet Digital PCR to Measure Immunotherapy – Technology Networks
Technology Networks |
ASCO Annual Meeting Highlights Benefits of Droplet Digital PCR to Measure Immunotherapy
Technology Networks In one ASCO study, physicians used ddPCR technology to distinguish between tumor growth and pseudoprogression — a common conundrum in cancer immunotherapy. Tumors can appear to grow before they begin to shrink as a result of treatment, … |
